[Form 4] EyePoint, Inc. Insider Trading Activity

Rhea-AI Filing Summary

EyePoint, Inc. Chief Financial Officer Elston George reported multiple equity compensation transactions and related share issuances and tax withholdings in early January 2026. On January 2, 2026, he received 63,000 restricted stock units and a stock option for 126,000 shares, both at an exercise or conversion price of $0.00, with the RSUs vesting in three annual installments beginning January 2, 2027 and the option vesting 25% on January 2, 2027 and the remainder monthly over three years. On January 3 and 5, 2026, previously granted RSUs vested and converted into a total of 34,667 shares of common stock, with 6,324 and 4,403 shares withheld at prices of $17.48 and $17.43 to satisfy tax obligations, and no shares sold into the market. Following these transactions, he directly held 81,054 shares of common stock and derivative awards, and an additional 25,000 shares are held indirectly by a family trust for his children, for which he disclaims beneficial ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Elston George

(Last) (First) (Middle)

C/O EYEPOINT, INC.

480 PLEASANT STREET, SUITE C400

(Street)

WATERTOWN MA 02472

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EyePoint, Inc. [ EYPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/03/2026		M		19,667	A	$0.00	76,781	D
Common Stock	01/03/2026		F		6,324	D	$17.48(1)	70,457	D
Common Stock	01/05/2026		M		15,000	A	$0.00	85,457	D
Common Stock	01/05/2026		F		4,403	D	$17.43(1)	81,054	D
Common Stock								25,000	I	By Family Trust(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0.00	01/02/2026		A		63,000		(3)	(3)	Common Stock	63,000	$0.00	63,000	D
Stock Option (Right to Buy)	$17.48	01/02/2026		A		126,000		(4)	01/02/2036	Common Stock	126,000	$0.00	126,000	D
Restricted Stock Units	$0.00	01/03/2026		M			19,667	(5)	(5)	Common Stock	19,667	$0.00	39,333	D
Restricted Stock Units	$0.00	01/05/2026		M			15,000	(6)	(6)	Common Stock	15,000	$0.00	15,000	D

Explanation of Responses:

1. No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units.

2. These securities are held in a trust for the benefit of the reporting person's children. JP Morgan Trust Company of Delaware is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

3. The restricted stock units will vest in three ratable annual installments beginning January 2, 2027.

4. The option to purchase will vest and become exercisable as follows: 25% at January 2, 2027 and the remainder ratably, on a monthly basis, over the remaining three years.

5. The restricted stock units vest in three ratable annual installments beginning January 3, 2026.

6. The restricted stock units vest in three ratable annual installments beginning January 5, 2025.

Remarks:

	/s/ Ron Honig, Attorney-in-Fact	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.